Vascular Patches Market is expected to See Incredible Growth By 2032

Global vascular patches market demand is expected to increase by 5.8% from 2021 to 2031, with a market value of around US$ 136.9 million in 2021. Vascular Patches market is expected to reach US$ 241.4 Million by 2031. According to Future Market Insights (FMI), biologic vascular patches by materials held a 52.9% share of the global market in 2020.

There is a global increase in the prevalence of cardiovascular diseases. The rising prevalence of cardiac disorders will boost the vascular patches market. Vascular patches have emerged as a new avenue for revenue generation for biopharmaceutical and pharmaceutical companies. Increasing technological advancements within the cardiac therapeutic sphere have assisted the soaring adoption of vascular patches for revascularization as effective means for therapeutic usage of vascular patches.

The unmet needs for cardiological treatments are addressed by the growing availability of high-quality patch products worldwide. Increasing lifestyle changes such as physical inactivity, tobacco consumption and smoking, as well as an unhealthy diet are prime factors responsible for the growing burden of cardiovascular diseases.

The emergence of cardiac management has advanced the diagnostic approach to increase life expectancy as well as management, thus propelling the growth of the vascular patches market.

Key players active within the market are focusing on the development of novel products using existing biologic resources for innovative product identification, as well as the provision of patented therapies. Furthermore, the occurrence of adverse conditions such as organ failure and stroke in cardiac cases through the process of surgical management has motivated the adoption of vascular patches among major healthcare facilities over the globe.

Key Players

  • Braile Biomedica
  • Baxter International
  • Getinge Ab (Maquet)
  • B. Braun Melsungen AG
  • W. L. Gore & Associates
  • Admedus
  • Cryolife
  • Edwards Lifesciences
  • Others

Browse More Details@ https://www.futuremarketinsights.com/reports/vascular-patches-market

Key Market Segments Covered in Vascular Patches Industry Research

By Material:

  • Synthetic vascular patches
  • Biologic vascular patches

By Application:

  • Carotid Endarterectomy
  • Open Repair of Abdominal Aneurysm
  • Vascular bypass Surgery
  • Peripheral vascular reconstruction
  • Others

By End User:

  • Hospitals
  • Trauma Care Centers
  • Academic & Research Institutes

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more